These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3885893)

  • 21. Mycobacterium bovis infection.
    Holdiness MR
    Arch Intern Med; 1985 Oct; 145(10):1930. PubMed ID: 3899041
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental model of the short-course chemotherapy (author's transl)].
    Toyohara M
    Kekkaku; 1979 Jul; 54(7):369-74. PubMed ID: 513435
    [No Abstract]   [Full Text] [Related]  

  • 23. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 24. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis].
    Baba H; Shinkai A; Izuchi R; Azuma Y
    Kekkaku; 1987 Oct; 62(10):511-20. PubMed ID: 3444194
    [No Abstract]   [Full Text] [Related]  

  • 27. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision].
    Dai YS; Li Q; Duanmu HJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of polychemotherapy in patients with newly detected destructive pulmonary tuberculosis].
    Berezovskiĭ BA; Popova II; Pshevorskiĭ VIa
    Probl Tuberk; 1990; (4):50-2. PubMed ID: 2118644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated mycobacterium bovis infection in an immunocompetent host.
    Schübel N; Rupp J; Gottschalk S; Zabel P; Dalhoff K
    Eur J Med Res; 2006 Apr; 11(4):163-6. PubMed ID: 16720281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of Mycobacterium bovis in epidemiology of tuberculosis].
    Krebs A; Käppler W
    Z Erkr Atmungsorgane; 1982; 158(1-2):101-9. PubMed ID: 7041439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Abdominal tuberculosis and open lung tuberculosis caused by mycobacterium bovis].
    Danuser H; Mark G; Gartmann J; Rüedi T
    Schweiz Med Wochenschr; 1989 Apr; 119(15):467-72. PubMed ID: 2655075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy of pulmonary tuberculosis].
    Zbikowski H
    Pneumonol Pol; 1980 Jun; 48(6):393-8. PubMed ID: 6773038
    [No Abstract]   [Full Text] [Related]  

  • 34. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis.
    Patel N; Deshpande MM; Shah M
    J Indian Med Assoc; 2002 Mar; 100(3):191-3. PubMed ID: 12408283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 39. [Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
    Yamamoto K
    Kekkaku; 1978 Aug; 53(8):401-6. PubMed ID: 703041
    [No Abstract]   [Full Text] [Related]  

  • 40. Tuberculosis due to drug-resistant Mycobacterium bovis in pregnancy.
    Signorini L; Matteelli A; Bombana E; Pinsi G; Gulletta M; Tebaldi A; Carosi G
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):342-3. PubMed ID: 9559408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.